http://www.medpagetoday.com/MeetingCoverage/AAN/19543
TORONTO -- An investigational drug combination was safe and effective at relieving the symptoms of the inappropriate emotional expression sometimes linked to neurological diseases and injuries, a researcher said here.
In an open-label study, the combination of dextromethorphan and quinidine significantly reduced the symptoms of pseudobulbar affect in patients with multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS), according to Erik Pi
آی-ویدئو